NORMA Contract Research Organisation for Clinical Trials
NORMA conducts clinical trials, phase I–IV, for international pharmaceutical and biotech companies, through a network of subsidiaries in the Nordic and Baltic countries.
Contract research organisation for clinical trials in northern Europe
We work together as an enthusiastic and service-orientated team to deliver outstanding work. Our flexibility and professionalism have earned us recognition among our clients and is reflected in substantial repeat business.
A recent survey of customer perception among our large customers showed that ‘high quality’ and ‘flexibility’ are the primary reasons for choosing NORMA as their monitoring company. In additon, ‘project team devoted to study’ and ‘geographic reach / presence’ are important factors.
The working climate at NORMAS’s offices is positive and friendly and we strive to keep a low staff turnover.
CRO for clinical trials in various therapeutic areas
NORMA has over 90 employees, including experienced project managers, clinical research associates and clinical trials assistants. NORMA has 19 years of experience and has participated in more than 300 clinical trials across a wide range of therapeutic areas, including:
- Cardiovascular disorders: AMI, angina pectoris, hypertension, PAD and ACS
- CNS: depression, schizophrenia, Alzheimer’s dementia, epilepsy, MS, Parkinson’s disease and pain
- Dermatology: psoriasis and PLE / PMLE
- Endocrinology: diabetes, HRT, oral contraceptives and osteoporosis
- Infection: HIV, vaccines and herpes zoster
- Gastrointestinal disorders: ulcerative colitis, Crohn’s disease and collagenous colitis
- Oncology: breast cancer, prostate cancer, head-and-neck, leukaemia, solid tumours and malignant melanoma
- Immunology: arthritis and osteoarthrosis
- Medical devices: cardiac stents, urethral catheters and suction bags
NORMA has a strong client base with 80% repeat business due to a high level of quality. NORMA has a vast and valid network of potential investigators, and is a flexible and co-operative business partner.
Contract research services for clinical trials
NORMA staff work according to client or NORMA SOPs:
- Recruitment and evaluation of investigators
- GCP training of investigators and site staff
- Submissions to medicines agencies and ethics committees
- Organisation of investigator meetings
- Protocol writing
- CRF design
- Regular monitoring of phase I-IV trials
- Reporting to sponsor
- Medical monitoring
- Outsourcing of CRAs and CTAs
NORMA covers the entire Nordic and Baltic region in northern Europe, with offices in Denmark, Finland, Norway, Sweden, Estonia and Lithuania.
All these countries follow the general EU guidelines for approval of clinical trials; however, there are additional national – or even local – guidelines to follow. The local offices work competently and efficiently according to guidelines to meet and surpass client expectations.
Products and Services
Afinitor Disperz (everolimus) for the Treatment of TSC-Associated Partial-Onset Seizures
Lucemyra (lofexidine) for the Management of Opioid Withdrawal Symptoms
Fasenra (benralizumab) for the Treatment of Asthma
Austedo (deutetrabenazine) for the Treatment of Chorea Associated with Huntington’s Disease
Sublocade™ for the Treatment of Opioid Use Disorder
Aliqopa (copanlisib) for the Treatment of Relapsed Follicular Lymphoma
Kymriah (tisagenlecleucel) for the Treatment of Acute Lymphoblastic Leukaemia
Vosevi™ for the Retreatment of Chronic Hepatitis C Virus Infection
Baxdela™ (delafloxacin) for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Truxima (rituximab) for the Treatment of Cancer
Alunbrig (brigatinib) for the Treatment of Non-Small Cell Lung Cancer (NSCLC)
Alecensa (alectinib) for the Treatment of ALK-positive Non-small Cell Lung Cancer (NSCLC)
Exondys 51 (eteplirsen) for the Treatment of Duchenne Muscular Dystrophy (DMD)
Tagrisso (osimertinib) For the Treatment of EGFR mutation in Non-Small Cell Lung Cancer
Cabometyx (cabozantinib) for Treatment of Patients with Advanced Renal Cell Carcinoma
Defitelio (defibrotide sodium) for the Treatment of Hepatic Veno-Occlusive Disease
Durlaza (aspirin) for Reducing Risk of Cardiovascular Events
Linn Liljeström Zeuthen MSc has been appointed managing director for NORMA. For the last two years Linn has worked as contract manager across all of NORMA's six units. She succeeds NORMA's founder Minga Liljeström who will remain closely involved with NORMA as chairwoman of thRead more
NORMA has been appointed a gazelle company 2009 by Greens Analysis Institute in collaboration with the daily newspaper Borsen and Soliditet in Denmark. A gazelle company is the name given to a company that is among the most rapidly growing in Denmark. It is characterised by a positive gRead more
J. Galvydzio 3, Room 108
Hemvärnsgatan 15, 10 tr.
171 54 Solna
Rajatorpantie 41 C